 DEVON, Pa., June 03, 2021 GLOBE NEWSWIRE -- Zynerba Pharmaceuticals, Inc. Nasdaq: ZYNE, the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting a poster today from 10:00 a.m. 11:00 a.m. ET in poster session II at the 2021 American Society of Clinical Psychopharmacology ASCP Annual Meeting. A copy of the poster is available on the Zynerba corporate website at 